English
Spain
Filter
11 items
Go beyond concepts. Access real-world AI use cases across industries — understand what worked, what didn’t, and what it actually takes to implement.
Go beyond concepts. Access real-world AI use cases across industries — understand what worked, what didn’t, and what it actually takes to implement.
Participants will gain the ability to interpret scientific and clinical evidence, develop regulatory documentation across the drug development lifecycle, and translate validated clinical data into compliant product labelling and regulatory submissions.
participants will be able to interpret global regulatory guidelines, develop regulatory submission strategies, prepare compliant dossiers, manage health authority communications, and ensure inspection readiness across the product lifecycle.
Participants will be able to understand core biostatistical concepts, interpret clinical trial data, differentiate between statistical and clinical significance, evaluate study results critically, and collaborate effectively with biostatistics teams.
Participants will be able to understand clinical documentation requirements, manage Trial Master Files effectively, apply document lifecycle controls, ensure regulatory compliance, and maintain audit-ready systems throughout the clinical trial process.
Participants will be able to interpret and apply ICH-GCP guidelines, ensure ethical conduct of clinical trials, maintain compliant documentation, manage protocol adherence, and prepare for regulatory inspections effectively.
Participants will gain ability to interpret lay summary regulatory requirements, write compliant and patient-friendly summaries, apply plain-language principles without scientific distortion, manage review and feedback cycles, and ensure submission-ready disclosure aligned with global health authority expectations.
Regulatory Framework for Clinical Operations
Participants will learn to Apply clinical trial regulatory requirements seamlessly across planning, conduct, and oversight to prevent common compliance failures that lead to trial delays and inspection findings, while strengthening inspection readiness through disciplined documentation and effective oversight, and enabling informed operational decision-making that consistently safeguards patient safety and ensures data integrity.
